Dr. MacRae and his team seeks to understand the genetics behind common cardiovascular disease. Using the award, the research team plans to study and discover new genetic, molecular and cellular markers of coronary heart disease that could screen the population to identify individuals at risk of developing the disease.
“We’re no longer going to wait for a patient to show up with complaints or symptoms or something I recognize as a problem,” Dr. MacRae said in a statement. “We’re going to actively go out and look for their problems earlier and earlier, and find the most fundamental mechanisms of the disease.”
Verily, AHA and AstraZeneca selected Dr. MacRae’s project out of a pool of 349 applicants from 22 countries.
More articles on genomics:
Researchers discover gene that correlates with increased ear infection risk in children
Study shows precision medicine treatment can lengthen survival in advanced cancer patients
University of Michigan School of Public Health joins Precision Medicine Initiative
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
